PropertyValue
?:abstract
  • As SARS-CoV-2 (COVID-19) overtakes the world, causing moderate to severe disease in about 15% of infected patients, COVID-19 is also found to have widespread effects throughout the body with a myriad of clinical manifestations including the endocrine system This manuscript reviews what is known about the impact of COVID-19 on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function Findings in this area are evolving, and long-term effects of infection remain an active area of further research
is ?:annotates of
?:creator
?:journal
  • J_Endocr_Soc
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • SARS-CoV-2 (COVID-19) and the Endocrine System
?:type
?:who_covidence_id
  • #910257
?:year
  • 2020

Metadata

Anon_0  
expand all